According to a report by InsightAce Analytic, the Global Radiopharmaceuticals Market is valued at approximately US$ 8.8 billion in 2022 and is projected to grow to US$ 15.9 billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.89% from 2023 to 2031. The market encompasses various radioisotopes used in medical imaging and therapy for conditions such as cancer and heart disease. Key drivers for market growth include increasing demand for effective diagnostic and treatment tools, especially in oncology, and significant investments in research and development by pharmaceutical and biotechnology firms. However, strict regulatory challenges and the impact of the COVID-19 pandemic are likely to hinder growth. The North American region is expected to dominate the market, followed by significant contributions from Asia Pacific due to advancements in healthcare infrastructure and targeted treatments.
Fri, 06 Sep 2024 14:16:04 GMT | WhaTech